We invite you to view recent scientific poster presentation data. The posters are categorized by disease state. Click on the disease state below to view all posters in that category.
HRQoL and Work Productivity Improvements with Topical Delgocitinib vs Oral Alitretinoin in Chronic Hand Eczema: Phase 3 DELTA FORCE Results Andrea Bauer, Timo Buhl, Richard Woolf, James Greig, Jenny M. Norlin, Henrik Thoning, Ana Maria Giménez-Arnau < PREVIOUS POSTER NEXT POSTER > POSTER 35
Baseline Burden and Treatment History of Adolescents with Moderate-to-Severe Chronic Hand Eczema (CHE) Enrolled in the Randomized Phase 3 DELTA TEEN Trial Sonja Molin, Diana Rubel, Francisco J. Navarro-Triviño, Ziad Reguiai, Sofie De Schepper, James Halpern, Danielle Marcoux, John Su, Paweł Brzewski, F. Elcin Darendeli, Eydna Didriksen Apol, Henrik Thoning, Patrick Thøgersen, Lawrence F. Eichenfield < PREVIOUS POSTER NEXT POSTER > POSTER 36
The DELTA TEEN Phase 3 Trial: Systemic Exposure and Safety Profile of Delgocitinib Cream in Adolescents with Moderate-to-Severe Chronic Hand Eczema Sonja Molin, Eulalia Baselga, FJ Navarro-Triviño, Ziad Reguiai, Sofie De Schepper, James Halpern, Danielle Marcoux, John Su, Line Conradsen Hiort, Patrick Thøgersen, Diana Rubel < PREVIOUS POSTER NEXT POSTER > POSTER 37
Construction and Validation of a Photographic Guide for the Validated Investigator’s Global Assessment of Chronic Hand Eczema Scale (IGA-CHE) Andrea Bauer, Robert Bissonnette, Tove Agner, James Greig, Rie von Eyben, Jonathan Silverberg < PREVIOUS POSTER NEXT POSTER > POSTER 38
Sustained Health-Related Quality of Life improvements with Delgocitinib 20 mg/g Cream in Chronic Hand Eczema - Results from the Phase 3 Open-Label Extension DELTA 3 Trial April W. Armstrong, Linda Stein Gold, Andrea Bauer, James Greig, Jenny M. Norlin, Henrik Thoning, Tove Agner < PREVIOUS POSTER NEXT POSTER > POSTER 39
